These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 14652793)

  • 81. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.
    Teunissen CE; Iacobaeus E; Khademi M; Brundin L; Norgren N; Koel-Simmelink MJ; Schepens M; Bouwman F; Twaalfhoven HA; Blom HJ; Jakobs C; Dijkstra CD
    Neurology; 2009 Apr; 72(15):1322-9. PubMed ID: 19365053
    [TBL] [Abstract][Full Text] [Related]  

  • 82. From inflammation to degeneration: the lessons of clinical trials.
    Comi G
    Neurol Sci; 2003 Dec; 24 Suppl 5():S295-7. PubMed ID: 14652793
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Inflammation and degeneration in multiple sclerosis.
    Brück W; Stadelmann C
    Neurol Sci; 2003 Dec; 24 Suppl 5():S265-7. PubMed ID: 14652785
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Protecting axons in multiple sclerosis.
    Wilkins A; Scolding N
    Mult Scler; 2008 Sep; 14(8):1013-25. PubMed ID: 18632772
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Neuroprotection in multiple sclerosis: a therapeutic challenge for the next decade.
    Van der Walt A; Butzkueven H; Kolbe S; Marriott M; Alexandrou E; Gresle M; Egan G; Kilpatrick T
    Pharmacol Ther; 2010 Apr; 126(1):82-93. PubMed ID: 20122960
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The relation between MRI measures of inflammation and neurodegeneration in multiple sclerosis.
    Inglese M; Benedetti B; Filippi M
    J Neurol Sci; 2005 Jun; 233(1-2):15-9. PubMed ID: 15949493
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Early treatment.
    Comi G
    Neurol Sci; 2006 Mar; 27 Suppl 1():S8-12. PubMed ID: 16708191
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Molecular mechanisms of axonal damage in inflammatory central nervous system diseases.
    Neumann H
    Curr Opin Neurol; 2003 Jun; 16(3):267-73. PubMed ID: 12858061
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Macrophages and neurodegeneration.
    Hendriks JJ; Teunissen CE; de Vries HE; Dijkstra CD
    Brain Res Brain Res Rev; 2005 Apr; 48(2):185-95. PubMed ID: 15850657
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Inflammatory demyelination and neurodegeneration in early multiple sclerosis.
    Charil A; Filippi M
    J Neurol Sci; 2007 Aug; 259(1-2):7-15. PubMed ID: 17397873
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Pathology and definition of multiple sclerosis].
    Dutta R; Trapp BD
    Rev Prat; 2006 Jun; 56(12):1293-8. PubMed ID: 16948216
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Clinically isolated syndromes: predicting and delaying multiple sclerosis.
    Thrower BW
    Neurology; 2007 Jun; 68(24 Suppl 4):S12-5. PubMed ID: 17562845
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Axonal damage and its significance for the concept of neurodegeneration in multiple sclerosis].
    Recks MS; Bader J; Kaiser CC; Schroeter M; Fink GR; Addicks K; Kuerten S
    Fortschr Neurol Psychiatr; 2011 Mar; 79(3):161-70. PubMed ID: 21394707
    [TBL] [Abstract][Full Text] [Related]  

  • 94. New options for early treatment of multiple sclerosis.
    Tintoré M
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S9-S11. PubMed ID: 19200870
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Pathogenesis of brain and spinal cord atrophy in multiple sclerosis.
    Minagar A; Toledo EG; Alexander JS; Kelley RE
    J Neuroimaging; 2004 Jul; 14(3 Suppl):5S-10S. PubMed ID: 15228754
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ
    Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
    [TBL] [Abstract][Full Text] [Related]  

  • 97. MRI relapses have significant pathologic and clinical implications in multiple sclerosis.
    Traboulsee A
    J Neurol Sci; 2007 May; 256 Suppl 1():S19-22. PubMed ID: 17346748
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Axonal damage in multiple sclerosis].
    Bartosik-Psujek H; Stelmasiak Z
    Neurol Neurochir Pol; 2002; 36(3):505-12. PubMed ID: 12185807
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Immunomodulatory therapy in multiple sclerosis].
    Csépány T; Bereczki D
    Ideggyogy Sz; 2004 Nov; 57(11-12):401-16. PubMed ID: 15662768
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.